Computational approaches in the post-genomic era - how will we cope?
Related Experiment Video
Updated: Aug 6, 2026

Leveraging CyVerse Resources for De Novo Comparative Transcriptomics of Underserved (Non-model) Organisms
Published on: May 9, 2017
R Lahana1, D J. Church, N Terrett
1Vice-President R&D, Computational Drug Discovery, Synt:em, Nimes, France
Abstract:
The Discussion Forum provides a medium for airing your views on any issues related to the pharmaceutical industry and obtaining feedback and discussion on these views from others in the field. You can discuss issues that get you hot under the collar, practical problems at the bench, recently published literature, or just something bizarre or humorous that you wish to share. Publication of letters in this section is subject to editorial discretion and company-promotional letters will be rejected immediately. Furthermore, the views provided are those of the authors and are not intended to represent the views of the companies they work for. Moreover, these views do not reflect those of Elsevier, Drug Discovery Today or its editorial team. Please submit all letters to Rebecca Lawrence, News & Features Editor, Drug Discovery Today, e-mail: Rebecca.Lawrence@current-trends.com
More Related Videos
Related Concept Videos
Genomics
Evolutionary Relationships through Genome Comparisons
Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features.
Genome Annotation and Assembly
Maxam-Gilbert Sequencing
Challenges of the Maxam-Gilbert Method
The...
Modern Molecular Taxonomy

